Discovery of a monoacylglycerol lipase inhibitor that harnesses the therapeutic potential of endocannabinoid signaling without CNS-mediated adverse side effects or physical dependence.

ABSTRACT: Chemical proteomics of LEI-515 in mouse lung, liver and brain tissue to assess the selectivity of the inhibitor.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain, Lung, Liver

SUBMITTER: Mirjam Huizenga  

LAB HEAD: Prof.dr. Mario van der Stelt

PROVIDER: PXD042220 | Pride | 2023-10-09

REPOSITORIES: Pride